Motive Wealth Advisors Repligen Corp Transaction History

Motive Wealth Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$140.68 - $188.02 $165,299 - $220,923	-1,175 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$161.19 - $257.96 $11,283 - $18,057	-70 Reduced 5.62%	1,175 $221,000
Q4 2021 Feb 08, 2022	SELL	$247.59 - $304.47 $9,903 - $12,178	-40 Reduced 3.11%	1,245 $330,000
Q3 2021 Nov 16, 2021	SELL	$194.77 - $324.21 $973 - $1,621	-5 Reduced 0.39%	1,285 $371,000
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $213,972 - $285,025	1,290 New	1,290 $258,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Motive Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Motive Wealth Advisors with notifications on news.